Valuation : AstraZeneca PLC

Market Cap 252B 217B 204B 186B 349B 23,952B 351B 2,412B 938B 12,146B 945B 925B 40,216B P/E 2026 *
20.9x
P/E 2027 * 18.3x
Enterprise Value 271B 233B 219B 200B 376B 25,791B 378B 2,597B 1,010B 13,078B 1,018B 996B 43,303B EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.94x
Free-Float
96.63%
Yield 2026 *
2.06%
Yield 2027 * 2.19%
1 day-1.19%
1 week-2.44%
Current month-6.48%
1 month-6.48%
3 months-12.06%
6 months-20.88%
Current year-14.33%
1 week 11,650
Extreme 11650
12,476
1 month 11,404
Extreme 11404
12,476
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 Exercice

Chief Financial Officer

11,133 0.0007%
8/6/26 Free

SVP, Group Controller

2 0.0000% -
7/6/26 Free

See Remarks

2 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%-2.44%-0.30%+10.80% 252B
-1.52%-7.23%+57.90%+108.72% 1,031B
-0.82%-2.63%+50.05%+64.43% 641B
+0.37%-3.06%+21.87%+74.48% 453B
-2.35%-6.83%+32.63%+32.58% 349B
+3.56%+1.18%+26.31%+43.61% 290B
-0.59%-3.15%+49.83%+67.70% 232B
-0.10%-2.36%-19.97%-54.13% 201B
+0.45%-0.27%+29.84%+91.34% 181B
+1.79%+1.75%+14.94%-19.56% 162B
Average -0.15%-2.50%+26.31%+42.00% 379.2B
Weighted average by Cap. -0.52%-3.73%+35.87%+61.21%

Financials

2026 *2027 *
Net sales 63.25B 54.46B 51.13B 46.68B 87.69B 6,018B 88.32B 606B 236B 3,052B 237B 232B 10,105B 66.84B 57.55B 54.04B 49.33B 92.66B 6,360B 93.33B 640B 249B 3,225B 251B 246B 10,678B
Net income 12.02B 10.35B 9.72B 8.87B 16.67B 1,144B 16.79B 115B 44.81B 580B 45.14B 44.16B 1,921B 13.61B 11.72B 11B 10.04B 18.87B 1,295B 19B 130B 50.73B 657B 51.1B 49.99B 2,174B
Net Debt 19.33B 16.64B 15.62B 14.26B 26.79B 1,839B 26.98B 185B 72.03B 932B 72.56B 70.99B 3,087B 11.65B 10.03B 9.42B 8.6B 16.15B 1,109B 16.27B 112B 43.43B 562B 43.75B 42.8B 1,862B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-09-01 GBX 11,792.00 -1.49% 1,040,165
26-08-28 GBX 11,970.00 -1.19% 3,627,957
26-08-27 GBX 12,114.00 -0.98% 3,580,853
26-08-26 GBX 12,234.00 -1.94% 2,784,068
26-08-25 GBX 12,476.00 +3.02% 2,036,385
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
162.30USD
Average target price
212.66USD
Spread / Average Target
+31.03%

Quarterly revenue - Rate of surprise